To direct the heads of certain agencies to review and submit to Congress a report on public-private partnerships for combating the illicit fentanyl trade, and for other purposes.
Latest Action
Referred to the House Committee on the Judiciary.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™This bill, introduced in the 118th Congress as H.R. 9434, directs the heads of certain federal agencies to conduct a review and submit a report to Congress on public-private partnerships aimed at combating the illicit fentanyl trade. The bill focuses on evaluating existing collaborations between government entities and private sector organizations to address the challenges posed by fentanyl trafficking and related illicit activities. The bill was referred to the House Committee on the Judiciary but ultimately failed or expired without further legislative action. No full text or official summary is available to provide additional details on the scope or specific agencies involved.
H.R. 9434 sought to enhance congressional understanding of public-private efforts to combat illicit fentanyl trade through agency reporting but did not advance beyond committee referral and expired.
- The bill mandates agency heads to review and report on public-private partnerships targeting illicit fentanyl trade.
- It was introduced in the House and referred to the House Judiciary Committee on August 30, 2024.
- The bill did not progress and is currently classified as failed or expired.
['Federal agencies involved in drug enforcement and public health', 'Private sector partners collaborating on fentanyl interdiction', 'Congress, by receiving information to inform policy decisions']
['Lack of detailed provisions or funding mechanisms may limit implementation effectiveness.', 'The absence of enforcement or follow-up requirements could reduce accountability.', 'Without a full bill text, the scope of agency responsibilities and partnership definitions remain unclear.']
The bill was introduced during the 118th Congress amid ongoing concerns about the fentanyl crisis and the role of public-private partnerships in addressing illicit drug trade. Referral to the House Judiciary Committee aligns with the committee's jurisdiction over law enforcement and drug policy. The bill did not advance, reflecting either legislative priorities or procedural outcomes during the session.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Improved congressional insight into public-private collaborations could inform future legislative or regulatory actions on fentanyl enforcement.', 'Potential increased coordination between government and private sector entities if agencies act on review findings.', 'Possible administrative burden on agencies tasked with conducting reviews without additional resources.']
Transparency is limited by the absence of a full bill text and official summary, restricting detailed analysis. The bill’s failure to advance and lack of funding or enforcement language suggest limited immediate impact. Oversight considerations include ensuring that any mandated reports are comprehensive and that agencies have clear guidance and resources to fulfill requirements.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.